Eine Pressemitteilung die uns aufklärt was Europa nun „verabreicht“ wird!

McKotz, Südlich der Alpen, Freitag, 26.06.2020, 10:09 (vor 14 Tagen)6418 Views

Zitat 1:
There are limited clinical data available for Remdesivir. Serious and unexpected adverse events may occur that have not been previously reported with remdesivir use. Warnings: In clinical studies with remdesivir, infusion-related reactions and liver transaminase elevations have been observed.
Zitat 2:
Remdesivir is an investigational drug that has not been approved by the FDA for any use, and it is not yet known if remdesivir is safe or effective for the treatment of COVID-19.
Zitat 3:
There is the possibility of unfavorable results from ongoing and additional clinical trials involving remdesivir and the possibility that Gilead and other parties may be unable to complete one or more of such trials in the currently anticipated timelines or at all. Further, it is possible that Gilead may make a strategic decision to discontinue development of remdesivir or that FDA and other regulatory agencies may not approve remdesivir, and any marketing approvals, if granted, may have significant limitations on its use. As a result, remdesivir may never be successfully commercialized. In addition, Gilead may be unable to sufficiently scale up the production of remdesivir in the currently anticipated timelines, and Gilead may be unable to meet future supply needs. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.

https://www.marketwatch.com/press-release/gilead-announces-approval-of-veklury-remdesiv...

Die meistgelesenste Zeitschrift in DE weiß dazu folgendes zu berichten:
https://www.apotheken-umschau.de/Coronavirus/Wie-gut-hilft-Remdesivir-gegen-Covid-19-55...

Und da dies ein Börsenforum ist, noch (die geforderte) „Butter bei die Fische“ zu meinen letzten Beiträgen, vor allem zu jenem: „Alle kusche(l)n unter einer Decke“
Ich übersetze daraus die mir passenste Passage mit www.DeepL.com/Translator (kostenlose Version):
„Am 30. März, als Chinas Vermögensverwaltungsmarkt sich öffnete, waren die Vanguard Group und BlackRock die ersten beiden globalen Investitionsakteure, die in den Billionen-Dollar-Markt Chinas eindrangen und Lizenzen für die Gründung von hundertprozentigen Investmentfondsgesellschaften beantragten. [1]“
https://www.reddit.com/r/conspiracy/comments/g4l8p1/remdesivir_gilead_sciences_its_shar...

Und wer steht hinter diesen „Vermögensriesen“? Lieber „Tassie“ sende dem Forum eine Botschaft vom Himmel!

Mein Dank gilt dem Impulsgeber @Tempranillo, der „Remdesivir“ in den Fokus brachte:

Gehabt euch wohl!

--
"Die glücklichen Sklaven sind die erbittersten Feinde der Freiheit" (Marie von Ebner-Eschenbach, 1830-1916)


gesamter Thread:

RSS-Feed dieser Diskussion

Werbung

Wandere aus, solange es noch geht.